No Data
Sector Update: Health Care Stocks Mixed Late Afternoon
Amarin Shareholders Calls for Strategic Review
Express News | Amarin Shareholders Radoff and Torok: Amarin Board Should Immediately Announce, Run Strategic Review Maximizing Value for All Shareholders
Amarin Announces Additional in Vitro Data With EPA to Be Presented
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Amarin's Mixed Fortunes: Navigating U.S. Competition and European Growth Opportunities
